User:Windave/sandbox

From Wikipedia, the free encyclopedia

Dr. Chizoba Wonodi is the Nigeria Country Director, International Vaccine Access Centre (IVAC), Johns Hopkins Bloomberg School of Public Health. she is also the founder and national convener, Women Advocates for Vaccine Access (WAVA) a coalition of civil society organizations created to advocate for sustainable immunization financing in Nigeria. In the past, she worked as a physician in Nigeria, concentrating mostly on adolescent sexual, reproductive health and HIV/AIDs prevention before successfully attaining masters in public health at Johns Hopkins. She went on to the Dr.PH (Doctor of Public Health) program, completing both programs as a Gates Institute Scholar. She also worked as a surveillance officer and Medical Epidemiologist, Johns Hopkins Bloomberg School of Public Health, Immunization Advisor, Saving One Million Lives Initiative (SOML) and a research/teaching assistant, the Bill and Melinda Gates Institute Johns Hopkins Bloomberg School of Public Health.[1]

As the Country Director at IVAC, she is responsible for project development, proposal development, faculty recruitment, implementation oversight, donor and stakeholder management, documentation for the portfolio of projects in routine immunization, new vaccine introduction and sustainable immunization financing that IVAC undertakes in Nigeria.[2]

Biography and Education[edit]

Dr. Wonodi was born in Mbaise, Imo State. She graduated with a bachelor's degree from University of Benin, Edo State, Nigeria. She continued her studies at Johns Hopkins School of Public Health, Population and Family Health in Baltimore, Maryland, where she received her masters and doctorate degree in public health. [3]

Research[edit]

Dr. Wonodi has done a lot of research work out of which 11 peer review articles has been published, 7 submitted and in preparation for publication and 2 peer reviews completed (vaccines and bulletin of the World Health Organization). She also researched on:

Vaccine access and health systems, project/program Management and implementation, research on Pneumonia, Pneumococcal and Invasive Bacterial Disease. Among these research projects executed, her roles included principal investigator and co-investigator.

Some of these research topics include;

  • projects in Nigeria to strengthen routine immunization and vaccine delivery platform
  • The Fiscal Advocacy for Immunization in Nigeria through Advocacy Networks Coordination and Evidence (FAINANCE)[4]
  • Strengthening Training for Expanded Program on Immunization & Primary Health Care in Nigeria (STEP-IN)[5]
  •  Community distribution of Vaccine Indicator and Reminder (VIR) band[6]
  • Accountability Framework for Routine Immunization in Nigeria[7]
  •  Routine Immunization Consultants Of Nigeria (RICON)[8]
  • Landscape Analysis of Routine Immunization programs in Nigeria (LARI) [9]
  • Social Network Analysis of Vaccine Decision Making in Nigeria[10]
  • Vaccine Implementation Technical Advisory Committee (VITAC)

Dr. Wonodi was a member of the clinical epidemiology team for the Pneumonia Etiology Research for Child Health (PERCH) and member of project coordinating team for the Pneumococcal Conjugate Vaccine Impact Studies in the Gambia and Kenya

Her research interests lies at the intersection of policy and health systems research, with a bias for studies that have direct programmatic or policy application. She focuses on vaccine access, pneumonia and diarrheal control and HIV/AIDS as well as supply and demand-side strategies to improve coverage of health interventions. In addition, her work on reproductive health and HIV/AIDS in adolescents and adults centers on the prevention of reproductive health morbidity, prevention of HIV and HPV acquisition.

Pneumonia Etiology Research for Child Health[edit]

The PERCH (Pneumonia Etiology Research for Child Health) project is a multi-country, case-control study to determine the etiology of and risk factors for severe and very severe pneumonia in children 1-59 months of age. Laboratory techniques that have remained largely unchanged for many decades and analytic methods that are not able to address the challenges inherent in the data have limited our understanding of pneumonia etiology. By applying modern diagnostics with standardized methods across all sites, PERCH will contribute new, detailed information to inform the development of new vaccines and treatment approaches.[11]

Pneumococcal Conjugate Vaccine Impact Studies Gambia and Kenya[edit]

Using a passive-surveillance system established in 2003 at the Kilifi Health and Demographic Surveillance System, in Kilifi, Kenya, this project is a Phase IV, before-after study, examining the population impact of the 10-valent Pneumococcal Conjugate Vaccine (PCV), which was introduced into the Kenyan childhood immunization system in January 2011. The project examines both direct and indirect vaccine effects on the primary endpoint – invasive pneumococcal disease, as well as serotype replacement disease. It has reported the initial impact of the programme on pneumococcal carriage – indicating a significant effect on transmission of vaccine serotypes. The study will also report on the wider public health end-point of radiologicaly-confirmed pneumonia. The study is a collaboration with the Unit for Vaccines and Immunisation at the Ministry of Health in Kenya and also with partners at Johns Hopkins School of Public Health.[12]

Awards and Honors[edit]

2016: Youth solidarity award given by the Leadership Advancement Foundation, at the National Youth Leadership Conference (NYLC), which held in Abuja. Dr. Wonodi was recognized for her contributions to youth development in Nigeria

2008:  Caroline Cochrane award for Reproductive Health, Department of Population Family and Reproductive Health, Johns Hopkins School of Public Health.[13]

2007:   Population Reference Bureau Policy Fellow; a competitive fellowship open to all developing country public health students in the US and awarded to students whose research show strong promise for policy impact

2004:   The Bill and Melinda Gates Institute Scholarship for Doctorate in Public Health, a prestigious award given in recognition of academic excellence and public health career promise

2003:   The Bill and Melinda Gates Institute Scholarship for Masters in Public Health, a prestigious award given in recognition of academic excellence and public health career promise

Publications (Journal Articles (peer reviewed))[edit]

1.      Oconnell M, Wonodi CB. Routine immunization consultant program in Nigeria: a review of a country driven management approach for health systems capacity building. Global Health: Science and Practice. 2016;4(1):29-42. http://dx.doi.org/10.9745/GHSP-D-15-00209

2.      Wonodi CB, Privor-Dumm L, Aina M, Pate AM, Reis R, Gadhoke P, Levine OS. Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria. Health Policy Plan. 2012 May;27 Suppl 2:ii27-38.

3.      Wonodi CB, Deloria-Knoll M, Feikin DR, DeLuca AN, Driscoll AJ, Moïsi JC, Johnson HL, Murdoch DR, O'Brien KL, Levine OS, Scott JA; Pneumonia Methods Working Group and PERCH Site Investigators. Evaluation of risk factors for severe pneumonia in children: the Pneumonia Etiology Research for Child Health study. Clin Infect Dis. 2012 Apr;54 Suppl 2:S124-31.

4.      Scott JA, Wonodi CB, Moïsi JC, Deloria-Knoll M, DeLuca AN, Karron RA, Bhat N, Murdoch DR, Crawley J, Levine OS, O'Brien KL, Feikin DR; Pneumonia Methods Working Group. The definition of pneumonia, the assessment of severity, and clinical standardization in the Pneumonia Etiology Research for Child Health Study. Clin Infect Dis. 2012 Apr;54 Suppl 2:S109-16.

5.      Turner GD, Bunthi C, Wonodi CB, Morpeth SC, Molyneux CS, Zaki SR, Levine OS, Murdoch DR, Scott JA. The role of postmortem studies in pneumonia etiology research. Clin Infect Dis. 2012 Apr;54 Suppl 2:S165-71.

6.      Knoll MD, Moïsi JC, Muhib FB, Wonodi CB, Lee EH, Grant L, Gilani Z, Anude CJ, O'Brien KL, Cherian T, Levine OS; PneumoADIP-Sponsored Surveillance Investigators. Standardizing surveillance of pneumococcal disease. Clin Infect Dis. 2009 Mar 1;48 Suppl 2:S37-48.

7.      O.K Obunge, L. Brabin, N. Dollimore, J. kemp, C. Ikokwu-Wonodi, S. Babatunde, S. White, N.D. Briggs, C.A. Hart  " A flowchart for managing sexually transmitted infections among Nigerian adolescent females" Bulletin of the World Health Organization, 2001; 79(4)

8.      Ikimalo J, Kemp J, Obunge O, Babatunde S, Ikokwu-Wonodi C, Abgaje O, Dollimore N, Hart C, Brabin L, Briggs N. "Sexually Transmitted Infections among Nigerian adolescent school girls" Sexually Transmitted Infections 1999; 75(2): 121

9.      Brabin L, Ikimalo J Dollimore N, Kemp J, Ikokwu-Wonodi C, Babatunde S, Obunge O, Briggs N, "How do they grow?- A study of south eastern Nigerian adolescent girls" Acta Paediatrica 1997; 86: 1114-20

Reference[edit]

  1. ^ Health, JH Bloomberg School of Public. "A Conversation with Chizoba Wonodi, Epidemiologist & Nigeria Country Director, IVAC". Johns Hopkins Bloomberg School of Public Health. Retrieved 2017-11-04.
  2. ^ "IVAC names Dr. Chizoba Wonodi Nigeria Country Director".
  3. ^ Dr. Chizoba, Wonodi. "Governance | HSDF". HSDF. Retrieved 2017-11-04.
  4. ^ "Fiscal Advocacy for Immunization in Nigeria through Advocacy Networks Coordination and Evidence (FAINANCE) project". Direct Consulting and logistics. 2016-03-14. Retrieved 2017-11-05.
  5. ^ "Strengthening Training for Expanded Programme In Immunization (EPI) and Primary Health Care (PHC) in Nigeria. STEP-IN". Direct Consulting and logistics. 2016-03-14. Retrieved 2017-11-05.
  6. ^ "Vaccine Indicator and Reminder band, Nigeria-3ie:International Initiative for Impact Evaluation | Evaluating Impact, Informing Policy, Improving Lives". www.3ieimpact.org. Retrieved 2017-11-05.
  7. ^ "Accountability Framework for Routine Immunization in Nigeria (AFRIN)". Direct Consulting and logistics. 2016-03-14. Retrieved 2017-11-06.
  8. ^ O'Connell, M.; Wonodi, C. (2015-01-01). "Routine immunization consultants (RICON) review in Nigeria: A country driven management approach for health systems strengthening in routine immunization". Annals of Global Health. 81 (1): 183–184. doi:10.1016/j.aogh.2015.02.920. ISSN 2214-9996.
  9. ^ Smith, Mike. "LARI Report Released". Johns Hopkins Bloomberg School of Public Health. Retrieved 2017-11-06.
  10. ^ Wonodi, C. B.; Privor-Dumm, L.; Aina, M.; Pate, A. M.; Reis, R.; Gadhoke, P.; Levine, O. S. (May 2012). "Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria". Health Policy and Planning. 27 Suppl 2: ii27–38. doi:10.1093/heapol/czs037. ISSN 1460-2237. PMID 22513730.
  11. ^ Smith, Mike. "PERCH - Pneumonia Etiology Research for Child Health". Johns Hopkins Bloomberg School of Public Health. Retrieved 2017-11-06.
  12. ^ "Pneumococcal Conjugate Vaccine Impact Study - The Vaccine Centre". The Vaccine Centre. 2016-09-13. Retrieved 2017-11-06.
  13. ^ Grillo, Christine. "Honors and Awards 2008". Johns Hopkins Bloomberg School of Public Health. Retrieved 2017-11-04.

External Links[edit]

IVAC

WAVA

Pneumonia Etiology Research for Child Health

Retrieved from "https://en.wikipedia.org/w/index.php?title=User:Windave/sandbox&oldid=1092580730"